Shiro Yamaguchi

Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma

Yoshiaki Yamamoto, Junji Yatsuda, Mototsugu Shimokawa et al. · International Journal of Clinical Oncology · 2020 · 41 citations

Medicine, Oncology, Pharmacotherapy +10

Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥75 years after radical cystectomy for treatment of bladder cancer

Hideyasu Matsuyama, Yoriaki Kamiryo, Shigeaki Hayashida et al. · International Journal of Clinical Oncology · 2015 · 33 citations

Medicine, Surgery, Urology +11

Allelic loss of 3p25 associated with alterations of 5q22.3∼q23.2 may affect the prognosis of conventional renal cell carcinoma

Kazuhiro Nagao, Shiro Yamaguchi, Hideyasu Matsuyama et al. · Cancer Genetics and Cytogenetics · 2005 · 25 citations

Medicine, Molecular Genetics, Oncology +8

Clinical significance of lymph node dissection in renal cell carcinoma

Hideyasu Matsuyama, Hiroshi Hirata, Yoshihito Korenaga et al. · Scandinavian Journal of Urology and Nephrology · 2005 · 17 citations

Medicine, Oncology, Surgery +17

Identification of curable high-risk prostate cancer using radical prostatectomy alone: who are the good candidates for undergoing radical prostatectomy among patients with high-risk prostate cancer?

Kazuhiro Nagao, Hideyasu Matsuyama, Hiroaki Matsumoto et al. · International Journal of Clinical Oncology · 2018 · 10 citations · Full text

Medicine, Oncology, Urology +14